331 related articles for article (PubMed ID: 12425880)
1. Clinical relevance of mechanisms of antifungal drug resistance in yeasts.
Sanglard D
Enferm Infecc Microbiol Clin; 2002 Nov; 20(9):462-9; quiz 470, 479. PubMed ID: 12425880
[TBL] [Abstract][Full Text] [Related]
2. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
3. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
4. Antifungal drug resistance mechanisms.
Pemán J; Cantón E; Espinel-Ingroff A
Expert Rev Anti Infect Ther; 2009 May; 7(4):453-60. PubMed ID: 19400764
[TBL] [Abstract][Full Text] [Related]
5. Resistance of yeasts to azole-derivative antifungals.
Odds FC
J Antimicrob Chemother; 1993 Apr; 31(4):463-71. PubMed ID: 8514644
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of resistance to azole antifungals.
Lupetti A; Danesi R; Campa M; Del Tacca M; Kelly S
Trends Mol Med; 2002 Feb; 8(2):76-81. PubMed ID: 11815273
[TBL] [Abstract][Full Text] [Related]
7. [Antifungals for systemic use].
Ruiz-Camps I; Cuenca-Estrella M
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):353-62. PubMed ID: 19482382
[TBL] [Abstract][Full Text] [Related]
8. [Antifungal agent resistance of yeasts of clinical significance].
Odds FC
Rev Clin Esp; 1995 Oct; 195 Suppl 3():56-7. PubMed ID: 9441307
[No Abstract] [Full Text] [Related]
9. [Antifungal susceptibility of emerging yeast pathogens].
García-Martos P; Domínguez I; Marín P; García-Agudo R; Aoufi S; Mira J
Enferm Infecc Microbiol Clin; 2001; 19(6):249-56. PubMed ID: 11440661
[TBL] [Abstract][Full Text] [Related]
10. Antifungal drug resistance to azoles and polyenes.
Masiá Canuto M; Gutiérrez Rodero F
Lancet Infect Dis; 2002 Sep; 2(9):550-63. PubMed ID: 12206971
[TBL] [Abstract][Full Text] [Related]
11. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
12. In vitro antifungal susceptibility pattern and ergosterol content in clinical yeast strains.
Gomez-Lopez A; Buitrago MJ; Rodriguez-Tudela JL; Cuenca-Estrella M
Rev Iberoam Micol; 2011; 28(2):100-3. PubMed ID: 21251996
[TBL] [Abstract][Full Text] [Related]
13. Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.
Biswas C; Chen SC; Halliday C; Kennedy K; Playford EG; Marriott DJ; Slavin MA; Sorrell TC; Sintchenko V
Clin Microbiol Infect; 2017 Sep; 23(9):676.e7-676.e10. PubMed ID: 28344162
[TBL] [Abstract][Full Text] [Related]
14. Antifungals.
Campoy S; Adrio JL
Biochem Pharmacol; 2017 Jun; 133():86-96. PubMed ID: 27884742
[TBL] [Abstract][Full Text] [Related]
15. Antifungals in Clinical Use and the Pipeline.
Johnson MD
Infect Dis Clin North Am; 2021 Jun; 35(2):341-371. PubMed ID: 34016281
[TBL] [Abstract][Full Text] [Related]
16. Antifungal drug resistance.
Loeffler J; Stevens DA
Clin Infect Dis; 2003 Jan; 36(Suppl 1):S31-41. PubMed ID: 12516028
[TBL] [Abstract][Full Text] [Related]
17. The effect of antifungal resistance development on the virulence of Candida species.
Bohner F; Papp C; Gácser A
FEMS Yeast Res; 2022 Apr; 22(1):. PubMed ID: 35325128
[TBL] [Abstract][Full Text] [Related]
18. Antifungal drug resistance: does it matter?
Rogers TR
Int J Infect Dis; 2002 Mar; 6 Suppl 1():S47-53. PubMed ID: 12044289
[TBL] [Abstract][Full Text] [Related]
19. Elucidating drug resistance in human fungal pathogens.
Xie JL; Polvi EJ; Shekhar-Guturja T; Cowen LE
Future Microbiol; 2014; 9(4):523-42. PubMed ID: 24810351
[TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibility patterns of yeast isolates causing bloodstream infections.
Barchiesi F; Caggiano G; Maracci M; Arzeni D; Scalise G; Montagna MT
J Antimicrob Chemother; 2003 Feb; 51(2):431-3. PubMed ID: 12562717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
